MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.New data from the ARCHER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback